Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

September 05, 2015 5:07 AM ET

Healthcare Equipment and Supplies

Company Overview of USGI Medical, Inc.

Company Overview

USGI Medical, Inc. engages in the development of technologies that enable incision less surgery. Its products include TransPort, an endosurgical operating platform that provides stable access to the operating site through a natural orifice or an incision in the umbilicus; g-Prox, a grasping/tissue approximation device; g-Cath, a tissue anchor delivery catheter; and g-Lix, a helical endoscopic tissue grasper. The company’s products are used in endolumenal applications. USGI Medical, Inc. was incorporated in 2001 and is based in San Clemente, California.

1140 Calle Cordillera

San Clemente, CA 92673

United States

Founded in 2001





Key Executives for USGI Medical, Inc.

Chief Executive Officer and President
Chairman and Advisor
Age: 55
Chief Operating Officer
Chief Technical Officer
General Manager of Flexible Surgery Division
Compensation as of Fiscal Year 2015.

USGI Medical, Inc. Key Developments

USGI Medical, Inc. Receives FDA Approval to Launch Head-to-Head Pivotal Study to Determine Safety, Effectiveness of Incisionless, Endoscopic Weight Loss Procedure

USGI Medical, Inc. has obtained conditional approval of its investigational device exemption (IDE) application from the U.S. Food and Drug Administration (FDA) to launch what the company believes to be the large multicenter, randomized, sham-controlled study of an endoscopic procedure for weight loss ever conducted. The company plans to enroll approximately 350 subjects at up to nine centers across the U.S. Physicians participating in the study will use USGI Medical's g-Cath EZ(TM) Suture Anchor Delivery Catheter to place tissue anchors across folds of tissue in strategically-located parts of the stomach to reduce its size and ability to stretch to accommodate a meal. The g-Cath, which is used extensively for general, non-obesity indications, is the first endoscopic suturing technology proven to create a durable, healed fold in the stomach. The incisionless outpatient procedure has been performed on over 2,000 patients, mostly in Europe, where it is known as "POSE." The procedure is performed entirely through the mouth without any incisions through the abdomen. Many patients have returned to work without any bandages or signs of surgery within two to three days.

Similar Private Companies By Industry

Company Name Region
Sensoria Inc. United States
Imetrx, Inc. United States
Pentron Clinical Technologies, LLC United States
Corinthian Ophthalmic, Inc. United States
evo Medical Solutions, Inc. United States

Recent Private Companies Transactions

Private Placement
January 26, 2015
Private Placement
November 4, 2014

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact USGI Medical, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at